Overview

Three-way Crossover Study Comparing Ondansetron ODFS Administered With and Without Water to Zofran ODT Without Water

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This study conducted in healthy male and female adult participants compared the bioavailability and relative safety and tolerance of a single dose of ondansetron 8 mg Orally Dissolving Filmstrip (ODFS) administered under fasting conditions with and without water with that of a single dose of Zofran Orally Dissolving Tablets (ODT®) containing ondansetron 8 mg administered under fasting conditions without water.
Phase:
Phase 1
Details
Lead Sponsor:
Aquestive Therapeutics
Par Pharmaceutical, Inc.
Treatments:
Ondansetron